Bolt Biotherapeutics, Inc. (BOLT)
4.63
+0.20
(+4.51%)
USD |
NASDAQ |
Jun 11, 16:00
4.63
0.00 (0.00%)
After-Hours: 17:56
Bolt Biotherapeutics Market Cap : 8.897M for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 8.513M |
| June 09, 2026 | 8.878M |
| June 08, 2026 | 9.07M |
| June 05, 2026 | 8.762M |
| June 04, 2026 | 9.147M |
| June 03, 2026 | 8.897M |
| June 02, 2026 | 9.819M |
| June 01, 2026 | 10.20M |
| May 29, 2026 | 10.09M |
| May 28, 2026 | 10.18M |
| May 27, 2026 | 10.14M |
| May 26, 2026 | 9.846M |
| May 22, 2026 | 9.501M |
| May 21, 2026 | 8.81M |
| May 20, 2026 | 8.848M |
| May 19, 2026 | 9.060M |
| May 18, 2026 | 8.369M |
| May 15, 2026 | 9.175M |
| May 14, 2026 | 9.597M |
| May 13, 2026 | 9.271M |
| May 12, 2026 | 9.175M |
| May 11, 2026 | 9.021M |
| May 08, 2026 | 8.964M |
| May 07, 2026 | 8.81M |
| May 06, 2026 | 8.81M |
| Date | Value |
|---|---|
| May 05, 2026 | 8.944M |
| May 04, 2026 | 9.712M |
| May 01, 2026 | 9.712M |
| April 30, 2026 | 9.213M |
| April 29, 2026 | 9.136M |
| April 28, 2026 | 9.290M |
| April 27, 2026 | 9.520M |
| April 24, 2026 | 9.271M |
| April 23, 2026 | 9.156M |
| April 22, 2026 | 10.35M |
| April 21, 2026 | 9.578M |
| April 20, 2026 | 9.885M |
| April 17, 2026 | 9.079M |
| April 16, 2026 | 9.232M |
| April 15, 2026 | 9.424M |
| April 14, 2026 | 9.098M |
| April 13, 2026 | 8.944M |
| April 10, 2026 | 9.424M |
| April 09, 2026 | 8.656M |
| April 08, 2026 | 8.829M |
| April 07, 2026 | 9.175M |
| April 06, 2026 | 9.463M |
| April 02, 2026 | 8.234M |
| April 01, 2026 | 8.656M |
| March 31, 2026 | 7.754M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sangamo Therapeutics, Inc. | 61.73M |
| Arrowhead Pharmaceuticals, Inc. | 10.46B |
| Oncolytics Biotech, Inc. | 95.55M |
| Sarepta Therapeutics, Inc. | 1.584B |
| Anixa Biosciences, Inc. | 83.32M |
Market Cap Related Metrics
| PS Ratio | 1.290 |
| PEG Ratio | -0.0040 |
| Price to Book Value | 0.4489 |
| Price | 4.63 |
| Earnings Yield | -352.8% |
| PEGY Ratio | -0.0040 |